(Press-News.org) ANN ARBOR--A team of researchers has discovered an antibody that blocks the ability of the dengue virus to cause disease in mice. The findings open the potential for developing effective treatments and designing a vaccine for dengue and similar diseases.
Dengue virus, a member of a group of viruses called flaviviruses, causes 50 to 100 million cases of dengue disease each year, with no effective treatment or vaccine. Other members of this group include the viruses that cause Zika, yellow fever and West Nile fever.
In a new study scheduled to publish Jan. 8 in the journal Science, researchers from the University of California, Berkeley, and the University of Michigan revealed how an antibody called 2B7 neutralizes one specific protein made by the virus--a protein that is key to the dengue virus's ability to both replicate and cause disease.
The protein, called NS1 (short for "non-structural protein 1") circulates in the patient's blood and exacerbates disease by interacting directly with endothelial cells, the cells that form protective barriers around organs. By breaking apart the connections between endothelial cells, NS1 weakens this barrier, increasing permeability and contributing to increased vascular leak, which is the hallmark of severe dengue disease. This endothelial permeability may also enable the virus to more easily cross barriers to infect and damage target organs.
The authors and other researchers had previously demonstrated that this protein itself can cause leaks in the endothelial barrier, even in the absence of infectious viral particles. And in cases of dengue virus infection, the more NS1 found circulating in the host's blood, the more severe the infection is likely to be.
"We think of bacterial toxins, but this idea of a viral toxin is a new concept," said Eva Harris, a professor of infectious diseases and vaccinology at UC Berkeley's School of Public Health and one of the study's senior authors. "This is really an important protein in terms of creating new paradigms regarding how we think about viral proteins and their functions in disease."
In this latest study, the researchers identified specific regions of the protein that are responsible for damaging the endothelial cells: a so-called wing region that allows the protein to connect to the host cells, and another region that triggers destructive events within the endothelial cells.
By analyzing the precise way that the 2B7 antibody attaches to the protein, they found that the antibody is able to neutralize both of these regions--simply by getting in the protein's way. The antibody connects to NS1 in such a way that the wing regions cannot reach the endothelial cells, preventing the protein from latching onto (and thus interacting with and damaging) the endothelial cells.
"This collaborative approach gives us a lot of great insight into understanding the biology of this protein, its interactions with cells and its pathogenesis," said David Akey, a researcher at the U-M Life Sciences Institute and a lead author of the study. "It's an example of combining structure and function to open therapeutic avenues."
One reason no effective therapeutic has been found for dengue is that the disease can be caused by one of four different virus strains (dengue virus 1, 2, 3 or 4). Having antibodies against one strain of the virus can actually increase severity of a subsequent infection from another strain, a phenomenon called antibody-dependent enhancement.
By binding only to the NS1 protein and not to the virus particle itself, however, the 2B7 antibody does not lead to antibody-dependent enhancement of the infection.
"These findings tell us that we can really have an effect on the virus's pathogenesis by blocking these sites on just the circulating proteins," said Janet Smith, a professor at the U-M Life Sciences Institute and U-M Medical School. "It offers a strategy not only for a therapy to treat an infection, but also for a vaccine to prevent infection."
And because the NS1 protein is produced by many flaviviruses, the scientists believe the antibody that targets NS1 may be useful in treating or preventing multiple flaviviruses.
"We were able to show not only the mechanism of how the antibody protects the host cells, but also the actual mechanism of pathogenesis of this protein that is conserved across other flaviviruses," Harris said.
"I think the fact that this antibody is cross-reactive with other flavivirus NS1 proteins is one of the most exciting elements of this work," said Scott Biering, a postdoctoral researcher in Harris's lab and a lead author of the study. "This research is the proof of concept that you can target this one protein for multiple flaviviruses to protect against pathogenesis. It opens a lot of avenues not only for better understanding the mechanics of this virus, but also for developing effective therapeutics."
INFORMATION:
The research was supported by the National Institutes of Health.
Study authors are: Scott B. Biering, Marcus P. Wong, Nicholas T.N. Lo, Henry Puerta-Guardo, Francielle Tramontini Gomes de Sousa, Chunling Wang, Diego A. Espinosa, Dustin R. Glasner, Jeffrey Li, Sophie F. Blanc, Evan Y. Juan, P. Robert Beatty and Eva Harris of the University of California, Berkeley; David L. Akey, W. Clay Brown, Jamie R. Konwerski, Nicholas J. Bockhaus and Janet L. Smith of the University of Michigan; Stephen J. Elledge of Brigham and Women's Hospital, the Howard Hughes Medical Institute and Harvard Medical School; and Michael J. Mina of the Harvard T.H. Chan School of Public Health.
"Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction," Science. DOI: 10.1126/science.abc0476. Once the embargo lifts, the paper will be available at https://science.sciencemag.org/cgi/doi/10.1126/science.abc0476
Christina Krienke and colleagues have designed an mRNA vaccine that delayed the onset of and reduced the severity of multiple sclerosis-like disease in mice. The vaccine restores the body's tolerance to its own proteins, suppressing the characteristic immune overreactivity of the disease. The vaccine developed by Krienke et al. works in a targeted fashion to promote tolerance to specific disease-related proteins, an improvement over other approaches to treating the disease that induce systemic immune suppression that can leave an individual vulnerable to other ...
Policymakers around the world tend to reference new and highly cited COVID-19 research papers in their policy documents regarding the pandemic, Yian Yin and colleagues conclude after analyzing publications of both types from the first half of 2020. "Overall, this result shows that the coronavirus research used by policymakers aligns with what scientists heavily engage themselves," they write in a Policy Forum. Although government agencies produced more COVID-19 documents compared to think tanks and intergovernmental organizations such as the World Health Organization, Yin et al. found that governmental agencies are the least likely to cite science. Organizations like WHO are the most likely institutions to cite science, they write, suggesting that these organizations can act ...
Social contact can transfer the feeling of pain or fear in several animal species, including humans, but the exact neural mechanisms for this transmission are still being studied. Now, Monique Smith and colleagues demonstrate that the social transmission of pain and pain relief in mice is mediated by neural projections from the brain's anterior cingulate cortex (ACC) to the nucleus accumbens. The transfer of fear, however, is mediated by the ACC's projections into a different area of the brain called the basolateral amygdala. The findings help untangle the distinct neural circuits involved ...
Richard Tyser and colleagues have mapped the origins of the embryonic mouse heart at single-cell resolution, helping to define the cell types that make up the heart in the earliest days of development. Their techniques allowed them to identify for a first time a pool of progenitor cells that contributes to the formation of heart muscle cells as well as the early epicardium, the outermost layer of the heart. This layer provides cells and other proteins that guide the development and repair of heart tissue, so a better understanding of its origins could better inform regenerative heart therapies as well as improve ...
New treatments to cut the global death rate from dengue, Zika and West Nile viruses could result from research led by The University of Queensland.
Associate Professor Daniel Watterson from UQ's School of Chemistry and Molecular Biosciences said the team identified an antibody that improved survival rates in laboratory trials and reduced the presence of virus in the blood.
"We made a discovery in 2015 in the wake of the Zika outbreak that identified a new target for flavivirus treatments, a viral protein called NS1," Dr Watterson said.
"Now we've shown for the first time that a single NS1 antibody can be protective against multiple flaviviruses including dengue, Zika and West Nile.
"No other antibody reported has shown such a broad range of protection.
"The improved ...
One essential component of each eukaryotic cell is the cytoskeleton. Microtubules, tiny tubes consisting of a protein called tubulin, are part of this skeleton of cells. Cilia and flagella, which are antenna-like structures that protrude from most of the cells in our body, contain many microtubules. An example of flagell is the sperm tail, which is essential for male fertility and thus for sexual reproduction. The flagellum has to beat in a very precise and coordinated manner to allow progressive swimming of the sperm. Failure to do so can lead to male infertility. Researchers at the Institut Curie in Paris, the Max Planck Institute of Molecular Cell Biology ...
Boulder, Colo., USA: The Yellowstone hotspot is well known for generating supereruptions in the geologic past that are far more explosive than historic examples. The origin and sustained longevity of the hotspot is less understood but is focused on two competing models, where the ascent of hot mantle is derived from either a deep-seated mantle plume or a shallow mantle source.
In their study published this month in GSA Today, Vic Camp and Ray Wells use an integrated database that supports the idea of a deep mantle-plume origin for the Yellowstone hotspot with a robust history of magmatism that extends to at least 56 million years ago, far older than previously thought. In this scenario, hotspot ...
Large perennial grasses like miscanthus are a primary target for use as bioenergy crops because of their sustainability advantages, but they take several years to establish and aren't ideal for crop rotation. Maize and other annual crops are easier to manage with traditional farming but are tougher on the environment.
Energy sorghum, a hefty annual plant with the ecological benefits of a perennial, may combine the best of both crops.
A study by researchers at the U.S. Department of Energy (DOE) Center for Advanced Bioenergy and Bioproducts Innovation (CABBI) found that energy sorghum (Sorghum bicolor) behaves more like miscanthus in the way it efficiently captures light and uses water to produce abundant biomass. ...
Tapping into an ancient evolutionary survival mechanism, cancer cells enter into a sluggish, slow-dividing state to survive the harsh environment created by chemotherapy or other targeted agents.
In research published January 7, 2020 in Cell, Princess Margaret Scientist Dr. Catherine O'Brien and team discovered that when under threat, all cancer cells - rather than just a subset - have the ability to transition into this protective state, where the cells "rest" until the threat, or chemotherapy, is removed.
It is the first study to identify that cancer cells hijack an evolutionary conserved program to survive chemotherapy. Furthermore, the researchers show that novel therapeutic strategies aimed at specifically targeting ...
If you've ever been in an operating room where tools are used to simultaneously cut and cauterize human flesh, you know what surgical smoke is. The heat generated by these surgical tools produces vapors made up of aerosolized chemicals and substances that can be hazardous to health.
Two new papers led by researchers in the University of Illinois Chicago College of Nursing suggest that policies and laws mandating the evacuation of surgical smoke from operating rooms are the best way to reduce the negative health impacts on perioperative staff as well as surgical patients.
Surgical smoke poses a health risk to everyone in the operating room. The smoke can sometimes be thick enough to obscure vision, especially during longer operations where cauterizing tools are heavily used. Perioperative ...
